Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dangschat T.O.H. GmbH & Co. KG is a Hamburg-based trading company specializing in the global supply of raw materials for the pharmaceutical, food, cosmetics, and chemical industries. Formed from the merger of Dangschat GmbH and Transozeanische Handels GmbH (TOH), the company leverages over 70 years of experience to provide high-quality ingredients and logistics solutions. Its pharmaceutical department focuses on sourcing and distributing pharma-grade raw materials, auxiliary materials, and active pharmaceutical ingredients (APIs) to manufacturers worldwide. The company also maintains a strong presence in the food and chemical sectors, offering products such as sweeteners, proteins, and industrial chemicals. Rooted in the Hanseatic merchant tradition, Dangschat T.O.H. emphasizes quality assurance, traceability, and long-term partnerships across its complex supply chains. The firm serves customers in over 40 countries, with a historical focus on the Latin American market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dangschat T.O.H.